Abstract:Triple-negative breast cancer (TNBC), with a lack of ERs, PRs, and HER2s as potential treatment targets, is insensitive to the hormonal and trastuzumab therapies and generally has a worse prognosis than other types of breast cancer. Thus, local and regional treatments such as radiotherapy are placed with more emphasis when treating patients with TNBC. By analyzing expression profiles of mRNAs, we provided a detailed landscape of the constituents of the tumor immune microenvironment to facilitate individualized treatment of patients with TNBC. Between January 1, 2010 and December 31, 2012, a total of 44 consecutive female patients diagnosed with a non-metastasized invasive TNBC who received adjuvant radiotherapy in our institution were identified in the present study. TNBC was defined as tumors with negative IHC for the ER (<1%), PR (<1%) and low or absent HER2-amplification (IHC 0 or 1+ or negative in situ hybridization). The Affymetrix Human Transcriptome Array 2.0 (HTA 2.0) GeneChips (Affymetrix) was used to determine the transcriptome profiles of 44 TNBC tissues samples. QRT-PCR was used to detected the expression of candidate RNAs. Gene set enrichment analysis (GSEA) was applied to investigate the functional associations of gene sets. CIBERSORT, a deconvolution algorithm enumerating infiltrating leucocytes, was performed to determine the relative fraction of 22 immune cell types in TNBC tumor tissues. Recurrence free survival (RFS) events included the following: the first recurrence of invasive disease at a local, regional, or distant site; contralateral breast cancer; and death from any cause. The median follow-up time was 51 months (range, 2.4–97.4 months). Fourteen patients (31.8%) developed disease recurrences. The 5-year accumulative RFS rate was 66.4%. By analyzing the transcriptome profiles of 14 patients with recurrence and 30 patients with no recurrence after radiotherapy, we observed that 281 mRNAs were up-regulated and 384 mRNAs were down-regulated in patients with recurrence, based on a p value cut-off of 0.05 and a greater than 1.2-fold change. GSEA revealed that gene sets related to immune responses are systematically down-regulated in patients with recurrence. We further determined the relative fraction of 22 immune cell types by using CIBERSORT. The most abundant cells were macrophages (39.4% of all leucocytes) with immunosuppressive M2 macrophages being the predominant population, followed by T cells (33.3% of all leucocytes). Increased M2 macrophages and resting mast cells were associated with high radiation resistance. In addition, we found that high expression of genes related to amino acid transportation correlated with inhibited immune responses and shorter RFS (p = 0.033). Our results suggested that immune response inhibition is significantly associated with radiation resistance in patients with TNBC with amino acid transportation might playing an important role.

Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.

Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation.

CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer

The PAD4 Inhibitor GSK484 Enhances the Radiosensitivity of Triple-Negative Breast Cancer

Transcriptome Profiling Reveals Inhibited Immune Responses Associated with Radiation Resistance in Triple-Negative Breast Cancer

Building Radiation-Resistant Model in Triple-Negative Breast Cancer to Screen Radioresistance-Related Molecular Markers

Downregulation of High Mobility Group Box 1 Modulates Telomere Homeostasis and Increases the Radiosensitivity of Human Breast Cancer Cells.

Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells

TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells

Overexpression of Tmprss4 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells

Endoplasmic reticulum stress regulates apoptosis and chemotherapeutic via enhancing TNFRSF10B recycling to the cell membrane in triple-negative breast cancer

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Radiation Enhances the Efficacy of EGFR-targeted CAR-T Cells Against Triple-Negative Breast Cancer by Activating NF-κB/Icam1 Signaling.

The Downregulation of CRIF1 Exerts Antitumor Effects Partially via TP53-Induced Glycolysis and Apoptosis Regulator Induction in BT549 Breast Cancer Cells

CXCR4 Antagonist AMD3100 Enhances the Response of MDA-MB-231 Triple-Negative Breast Cancer Cells to Ionizing Radiation.

Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis

Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy

TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer

Down regulation of lactotransferrin enhanced radio-sensitivity of nasopharyngeal carcinoma